Recurrent uncomplicated urinary tract infections: can young women diagnose and treat themselves?

PubWeight™: 0.75‹?›

🔗 View Article (PMC 1475963)

Published in Rev Urol on January 01, 2002

Authors

J Curtis Nickel

Articles by these authors

Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol (2002) 3.14

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology (2002) 2.94

Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82

Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA (2011) 2.80

Contemporary management of the painful bladder: a systematic review. Eur Urol (2011) 2.39

Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial. Urology (2011) 2.28

Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome. J Urol (2004) 1.76

Impact of medical therapy on transurethral resection of the prostate: two decades of change. BJU Int (2010) 1.73

Acupuncture ameliorates symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. Urology (2003) 1.68

Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study. Cancer (2013) 1.66

α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU Int (2012) 1.62

Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology (2002) 1.57

An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia. Can J Urol (2004) 1.56

Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med (2010) 1.55

A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol (2005) 1.54

Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA (2011) 1.46

Self-reported spousal support modifies the negative impact of pain on disability in men with chronic prostatitis/chronic pelvic pain syndrome. Urology (2011) 1.44

Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology (2003) 1.43

Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology (2009) 1.39

The chronic prostatitis-chronic pelvic pain syndrome can be characterized by prostatic tissue pressure measurements. J Urol (2002) 1.39

Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology (2010) 1.38

Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol (2002) 1.31

Benign prostatic hyperplasia: a progressive disease of aging men. Urology (2003) 1.31

Dietary patterns and risk of prostate cancer in Ontario, Canada. Int J Cancer (2005) 1.26

Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment. Can Fam Physician (2006) 1.22

Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain (2006) 1.22

Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology (2002) 1.21

Urogenital pain--time to accept a new approach to phenotyping and, as a consequence, management. Eur Urol (2007) 1.19

Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. J Urol (2010) 1.17

Chronic prostatitis/chronic pelvic pain syndrome and male interstitial cystitis: enigmas and opportunities. Urology (2007) 1.10

Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia. J Urol (2004) 1.09

Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology (2008) 1.09

Diagnosis and management of benign prostatic hyperplasia in primary care. Can Urol Assoc J (2009) 1.08

A feasibility trial of a cognitive-behavioural symptom management program for chronic pelvic pain for men with refractory chronic prostatitis/chronic pelvic pain syndrome. Can Urol Assoc J (2011) 1.04

Sexual functioning, catastrophizing, depression, and pain, as predictors of quality of life in women with interstitial cystitis/painful bladder syndrome. Urology (2009) 1.04

Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia. Clin Trials (2009) 0.99

Prevalence, symptom impact and predictors of chronic prostatitis-like symptoms in Canadian males aged 16-19 years. BJU Int (2008) 0.99

Cost-effectiveness of dutasteride-tamsulosin combination therapy for the treatment of symptomatic benign prostatic hyperplasia: A Canadian model based on the CombAT trial. Can Urol Assoc J (2013) 0.97

Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system. World J Urol (2013) 0.97

Comparison of clinical trials with finasteride and dutasteride. Rev Urol (2004) 0.97

Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology (2002) 0.96

A 2-year follow-up of quality of life, pain, and psychosocial factors in patients with chronic prostatitis/chronic pelvic pain syndrome and their spouses. World J Urol (2013) 0.95

Mapping of pain phenotypes in female patients with bladder pain syndrome/interstitial cystitis and controls. Eur Urol (2012) 0.92

Treatment of phimosis with topical steroids in 194 children. J Urol (2003) 0.92

National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol (2012) 0.89

Sexual and relationship functioning in men with chronic prostatitis/chronic pelvic pain syndrome and their partners. Arch Sex Behav (2006) 0.88

Interstitial cystitis/bladder pain syndrome and nonbladder syndromes: facts and hypotheses. Urology (2011) 0.87

Benign prostatic hyperplasia: does prostate size matter? Rev Urol (2003) 0.87

Plasma organochlorine levels and prostate cancer risk. J Expo Sci Environ Epidemiol (2009) 0.87

Practical management of recurrent urinary tract infections in premenopausal women. Rev Urol (2005) 0.85

Prostatitis and prostate cancer: implications for prostate cancer screening. Urology (2004) 0.84

Spousal support decreases the negative impact of pain on mental quality of life in women with interstitial cystitis/painful bladder syndrome. BJU Int (2010) 0.83

Changing paradigms for chronic pelvic pain: a report from the chronic pelvic pain/chronic prostatitis scientific workshop, october 19-21, 2005, Baltimore, MD. Rev Urol (2006) 0.83

Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo. J Urol (2007) 0.83

Efficacy of intravesical chondroitin sulphate in treatment of interstitial cystitis/bladder pain syndrome (IC/BPS): Individual patient data (IPD) meta-analytical approach. Can Urol Assoc J (2013) 0.82

Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin? J Urol (2007) 0.81

Understanding chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). World J Urol (2013) 0.81

Interstitial cystitis: characterization and management of an enigmatic urologic syndrome. Rev Urol (2002) 0.80

Diagnosis of interstitial cystitis June 2007. Can Urol Assoc J (2009) 0.80

Canadian Consensus Conference: The FDA decision on the use of 5ARIs. Can Urol Assoc J (2012) 0.80

Interstitial cystitis--an elusive clinical target? J Urol (2003) 0.79

Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned. J Urol (2011) 0.79

Chronic prostatitis-like symptoms in African males aged 16-19 years. Can J Urol (2012) 0.79

Association between response to pentosan polysulfate sodium therapy for interstitial cystitis and patient questionnaire-based treatment satisfaction. Curr Med Res Opin (2008) 0.79

A multi-site study confirms abnormal glycosylation in the Tamm-Horsfall protein of patients with interstitial cystitis. J Urol (2011) 0.79

Management of urinary tract infections in children: simplifying the controversies? Rev Urol (2003) 0.78

Quercetin for chronic prostatitis/chronic pelvic pain syndrome. Urol Clin North Am (2011) 0.77

Disability in women suffering from interstitial cystitis/bladder pain syndrome. BJU Int (2012) 0.77

Early symptom improvement of benign prostatic hyperplasia (BPH) treated with once daily alfuzosin. Can J Urol (2005) 0.76

Best of the 2013 AUA Annual Meeting: Highlights From the 2013 American Urological Association Meeting, May 4-8, 2013, San Diego, CA. Rev Urol (2013) 0.75

Re: a new high frequency electrostimulation device to treat chronic prostatitis. J Urol (2004) 0.75

Best of the 2009 AUA Annual Meeting: Highlights from the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL. Rev Urol (2009) 0.75

Pseudomonas aeruginosa bacteremia and prostatitis in a patient with cystic fibrosis. Can Urol Assoc J (2013) 0.75

Chronic epididymitis: a practical approach to understanding and managing a difficult urologic enigma. Rev Urol (2003) 0.75

Best of the AUA Annual Meeting: Highlights From the 2011 American Urological Association Meeting, May 14-19, 2011, Washington, DC. Rev Urol (2011) 0.75

Interstitial cystitis: the paradigm shifts: international consultations on interstitial cystitis. Rev Urol (2004) 0.75

Best of the 2008 AUA Annual Meeting: Highlights from the 2008 Annual Meeting of the American Urological Association, May 17-22, 2008, Orlando, FL. Rev Urol (2008) 0.75

Immunological based therapies for urinary tract infection: the future is almost here! Rev Urol (2002) 0.75

Editorial comment. Urology (2012) 0.75

alpha-Blockers for Treatment of the Prostatitis Syndromes. Rev Urol (2005) 0.75

Disappointing news for urologists managing interstitial cystitis patients. Rev Urol (2006) 0.75

Prostatitis/Chronic pelvic pain syndrome. Rev Urol (2002) 0.75

Antibiotics and alpha-Blockers for Chronic Prostatitis: Evidence From Recent Randomized Placebo-Controlled Studies. Rev Urol (2005) 0.75

Acupuncture for chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep (2004) 0.75

Best of the SIU Meeting on Prostatic Disease: Highlights from the Société Internationale d'Urologie Meeting on Prostatic Disease: Recent Advances and New Technologies, September 29-October 1, 2005, Bariloche, Patagonia, Argentina. Rev Urol (2005) 0.75

Lower urinary tract symptoms in men: A case-based discussion. Can Urol Assoc J (2012) 0.75

Prostatitis and chronic pelvic pain syndrome in men. Med Clin North Am (2010) 0.75

Clinical characterization of the prostatitis patient in Italy: a prospective urology outpatient study. World J Urol (2004) 0.75

Benign prostatic hyperplasia: from A - Z. Can J Urol (2003) 0.75

Benign prostatic hyperplasia: case scenarios. Rev Urol (2003) 0.75

Hypersensitivity reaction associated with intravesical bacillus Calmette-Guerin for interstitial cystitis. J Urol (2004) 0.75

The challenges of lower urinary tract symptoms in men. Can Urol Assoc J (2012) 0.75